Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isobutylamido thiazolyl resorcinol for prevention of UVB-induced hyperpigmentation
TCTR20200410001Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Oct 2019
- Countries
- 1
01
Overview
Phase 4 trial in Hyperpigmentation, sponsored by Ramathibodi Hospital. Started Oct 2019; status: completed.
02
Conditions
Hyperpigmentation
Beyond the preview
Go deeper on TCTR20200410001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200410001.